Corrections and Clarifications

Erratum

Science  20 Feb 1987:
Vol. 235, Issue 4791, pp. 832e-832
DOI: 10.1126/science.235.4791.832e

Abstract

In the News & Comment article "Court rejects Rifkin in biotech cases" by Mark Crawford (9 Jan., p. 159), the Food and Drug Administration (FDA) was incorrectly portrayed as having abandoned biotechnology guidelines issued by the Biotechnology Science Coordinating Committee. The agency continues to endorse the guidelines, but notes they "do not have specific regulatory significance for FDA."

Related Content